The ecology of antibiotic use in the ICU: Homogeneous prescribing of cefepime but not tazocin selects for antibiotic resistant infection

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Ginn, Andrew N ^a,b,c   Wiklendt, Agnieszka M ^a,b   Gidding, Heather F ^d   George, Narelle ^e   O'Driscoll, James S ^a   Partridge, Sally R ^a,b,c   O'Toole, Brian I ^a,b   Perri, Rita A ^c   Faoagali, Joan ^e,f   Gallagher, John E ^a   Lipman, Jeffrey ^g   Iredell, Jonathan R ^a,b,c  

^a WESTMEAD HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^f PRINCESS ALEXANDRA HOSPITAL   (Australia)

^g UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; CEFALOTIN; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; DICLOXACILLIN; FLUCLOXACILLIN; GENTAMICIN; LINEZOLID; MEROPENEM; METRONIDAZOLE; MOXIFLOXACIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; TEICOPLANIN; TIMENTIN; TOBRAMYCIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG USE; FEMALE; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MORTALITY; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION;

ADULT; AGED; ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; DRUG PRESCRIPTIONS; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NASOPHARYNX; PENICILLANIC ACID; PIPERACILLIN; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; STAPHYLOCOCCAL INFECTIONS; SURVIVAL RATE;

EID: 84862699119     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038719     Document Type: Article

References (49)

1. Kumar A, Haery C, Paladugu B, Kumar A, Symeoneides S, et al. (2006) The duration of hypotension before the initiation of antibiotic treatment is a critical determinant of survival in a murine model of Escherichia coli septic shock: association with serum lactate and inflammatory cytokine levels. J Infect Dis 193: 251-258.
2. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, et al. (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34: 1589-1596.
3. de Smet AM, Kluytmans JA, Cooper BS, Mascini EM, Benus RF, et al. (2009) Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 360: 20-31.
4. Oostdijk EA, de Smet AM, Blok HE, Thieme Groen ES, van Asselt GJ, et al. (2010) Ecological effects of selective decontamination on resistant Gram-negative bacterial colonization. Am J Respir Crit Care Med 181: 452-457.
5. Kollef MH, Vlasnik J, Sharpless L, Pasque C, Murphy D, et al. (1997) Scheduled change of antibiotic classes: a strategy to decrease the incidence of ventilator-associated pneumonia. Am J Respir Crit Care Med 156: 1040-1048.
6. Sandiumenge A, Diaz E, Rodriguez A, Vidaur L, Canadell L, et al. (2006) Impact of diversity of antibiotic use on the development of antimicrobial resistance. J Antimicrob Chemother 57: 1197-1204.
7. Warren DK, Hill HA, Merz LR, Kollef MH, Hayden MK, et al. (2004) Cycling empirical antimicrobial agents to prevent emergence of antimicrobial-resistant Gram-negative bacteria among intensive care unit patients. Crit Care Med 32: 2450-2456.
8. Brown EM, Nathwani D, (2005) Antibiotic cycling or rotation: a systematic review of the evidence of efficacy. J Antimicrob Chemother 55: 6-9.
9. Masterton RG, (2005) Antibiotic cycling: more than it might seem? J Antimicrob Chemother 55: 1-5.
10. Bergstrom CT, Lo M, Lipsitch M, (2004) Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals. Proc Natl Acad Sci U S A 101: 13285-13290.
11. Levin BR, Bonten MJ, (2004) Cycling antibiotics may not be good for your health. Proc Natl Acad Sci U S A 101: 13101-13102.
12. Yahav D, Paul M, Fraser A, Sarid N, Leibovici L, (2007) Efficacy and safety of cefepime: a systematic review and meta-analysis. Lancet Infect Dis 7: 338-348.
13. Antibiotic Expert Group (2010) Therapeutic guidelines: antibiotic. Melbourne: Therapeutic Guidelines Limited.
14. Breslow MJ, Badawi O, (2012) Severity scoring in the critically ill: part 1-interpretation and accuracy of outcome prediction scoring systems. Chest 141: 245-252.
15. Kho ME, McDonald E, Stratford PW, Cook DJ, (2007) Interrater reliability of APACHE II scores for medical-surgical intensive care patients: a prospective blinded study. Am J Crit Care 16: 378-383.
16. Knaus WA, Draper EA, Wagner DP, Zimmerman JE, (1985) APACHE II: a severity of disease classification system. Crit Care Med 13: 818-829.
17. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM, (1988) CDC definitions for nosocomial infections, 1988. Am J Infect Control 16: 128-140.
18. Banin E, Vasil ML, Greenberg EP, (2005) Iron and Pseudomonas aeruginosa biofilm formation. Proc Natl Acad Sci U S A 102: 11076-11081.
19. Malhotra-Kumar S, Abrahantes JC, Sabiiti W, Lammens C, Vercauteren G, et al. (2010) Evaluation of chromogenic media for detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 48: 1040-1046.
20. Summers WC, Brookings ES, Waites KB, (1998) Identification of oxacillin-susceptible and oxacillin-resistant Staphylococcus aureus using commercial latex agglutination tests. Diagn Microbiol Infect Dis 30: 131-134.
21. Murchan S, Kaufmann ME, Deplano A, de Ryck R, Struelens M, et al. (2003) Harmonization of pulsed-field gel electrophoresis protocols for epidemiological typing of strains of methicillin-resistant Staphylococcus aureus: a single approach developed by consensus in 10 European laboratories and its application for tracing the spread of related strains. J Clin Microbiol 41: 1574-1585.
22. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, et al. (1995) Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33: 2233-2239.
23. Merlino J, Siarakas S, Robertson GJ, Funnell GR, Gottlieb T, et al. (1996) Evaluation of CHROMagar Orientation for differentiation and presumptive identification of Gram-negative bacilli and Enterococcus species. J Clin Microbiol 34: 1788-1793.
24. Sarraf-Yazdi S, Sharpe M, Bennett KM, Dotson TL, Anderson DJ, et al. (2012) A 9-Year retrospective review of antibiotic cycling in a surgical intensive care unit. J Surg Res.
25. van Loon HJ, Vriens MR, Fluit AC, Troelstra A, van der Werken C, et al. (2005) Antibiotic rotation and development of Gram-negative antibiotic resistance. Am J Respir Crit Care Med 171: 480-487.
26. Cadena J, Taboada CA, Burgess DS, Ma JZ, Lewis JS 2nd, et al (2007) Antibiotic cycling to decrease bacterial antibiotic resistance: a 5-year experience on a bone marrow transplant unit. Bone Marrow Transplant 40: 151-155.
27. Sullivan A, Edlund C, Nord CE, (2001) Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect Dis 1: 101-114.
28. Beardmore RE, Pena-Miller R, (2010) Antibiotic cycling versus mixing: The difficulty of using mathematical models to definitively quantify their relative merits. Math Biosci Eng 7: 923-933.
29. Martinez JA, Nicolas JM, Marco F, Horcajada JP, Garcia-Segarra G, et al. (2006) Comparison of antimicrobial cycling and mixing strategies in two medical intensive care units. Crit Care Med 34: 329-336.
30. Jernberg C, Lofmark S, Edlund C, Jansson JK, (2010) Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology 156: 3216-3223.
31. Gilbert DN, Moellering RC, Elioppoulos GM, Chambers HF, Saag MS, editors (2009) Sanford Guide to Antimicrobial Therapy. 39th ed. USA: Antimicrobial Therapy, Inc.
32. Westphal JF, Brogard JM, Caro-Sampara F, Adloff M, Blickle JF, et al. (1997) Assessment of biliary excretion of piperacillin-tazobactam in humans. Antimicrob Agents Chemother 41: 1636-1640.
33. Antonopoulos DA, Huse SM, Morrison HG, Schmidt TM, Sogin ML, et al. (2009) Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infect Immun 77: 2367-2375.
34. Paterson DL, (2004) "Collateral damage" from cephalosporin or quinolone antibiotic therapy. Clin Infect Dis 38: S341-345.
35. de Araujo OR, da Silva DC, Diegues AR, Arkader R, Cabral EA, et al. (2007) Cefepime restriction improves Gram-negative overall resistance patterns in neonatal intensive care unit. Braz J Infect Dis 11: 277-280.
36. Nerandzic MM, Donskey CJ, (2011) Effect of ceftobiprole treatment on growth of and toxin production by Clostridium difficile in cecal contents of mice. Antimicrob Agents Chemother 55: 2174-2177.
37. Owens RC Jr, Donskey CJ, Gaynes RP, Loo VG, Muto CA, (2008) Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis 46: S19-31.
38. Lepelletier D, Caroff N, Riochet D, Bizouarn P, Bourdeau A, et al. (2006) Role of hospital stay and antibiotic use on Pseudomonas aeruginosa gastrointestinal colonization in hospitalized patients. Eur J Clin Microbiol Infect Dis 25: 600-603.
39. Rahal JJ, Urban C, Horn D, Freeman K, Segal-Maurer S, et al. (1998) Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. Jama 280: 1233-1237.
40. Borg MA, Zarb P, Scicluna EA, Rasslan O, Gur D, et al. (2010) Antibiotic consumption as a driver for resistance in Staphylococcus aureus and Escherichia coli within a developing region. Am J Infect Control 38: 212-216.
41. Villers D, Espaze E, Coste-Burel M, Giauffret F, Ninin E, et al. (1998) Nosocomial Acinetobacter baumannii infections: microbiological and clinical epidemiology. Ann Intern Med 129: 182-189.
42. Song X, Perencevich E, Campos J, Short BL, Singh N, (2010) Clinical and economic impact of methicillin-resistant Staphylococcus aureus colonization or infection on neonates in intensive care units. Infect Control Hosp Epidemiol 31: 177-182.
43. Schweizer ML, Furuno JP, Harris AD, Johnson JK, Shardell MD, et al. (2011) Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia. BMC Infect Dis 11: 279.
44. Paul M, Yahav D, Fraser A, Leibovici L, (2006) Empirical antibiotic monotherapy for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials. J Antimicrob Chemother 57: 176-189.
45. Towne TG, Lewis JS, Echevarria K, (2009) Efficacy and safety of cefepime. Lancet Infect Dis 9: 4-6; author reply 6-7.
46. Leibovici L, Yahav D, Paul M, (2010) Excess mortality related to cefepime. Lancet Infect Dis 10: 293-294.
47. Kim PW, Wu YT, Cooper C, Rochester G, Valappil T, et al. (2010) Meta-analysis of a possible signal of increased mortality associated with cefepime use. Clin Infect Dis 51: 381-389.
48. Kim PW, Nambiar S, (2010) Reply to Leibovici et. al. Clin Infect Dis 51: 1351-1352.
49. Leibovici L, Yahav D, Paul M, (2010) Meta-analysis of a possible signal of increased mortality associated with cefepime use. Clin Infect Dis 51: 1350-1351.